Cargando…
Sclerotic skin disease development following COVID-19 vaccination
Autores principales: | Sprow, Grant, Dan, Joshua, Abbott, James, Jiang, Angela, Diaz, DeAnna, Vazquez, Thomas, Kodali, Nilesh, Werth, Victoria P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864083/ https://www.ncbi.nlm.nih.gov/pubmed/35224171 http://dx.doi.org/10.1016/j.jdcr.2022.02.008 |
Ejemplares similares
-
260 Responses following COVID-19 vaccination in patients with autoimmune skin disease
por: Sprow, G., et al.
Publicado: (2022) -
Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination
por: Sprow, Grant, et al.
Publicado: (2022) -
Comparing dermatologic patient-reported outcome measures in cutaneous lupus erythematosus
por: Sprow, Grant, et al.
Publicado: (2022) -
Emerging Therapies in Cutaneous Lupus Erythematosus
por: Sprow, Grant, et al.
Publicado: (2022) -
Bullous systemic lupus erythematosus in females
por: Sprow, Grant, et al.
Publicado: (2022)